RecruitingNCT00453674

German Adrenocortical Carcinoma Registry

Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry

Sponsor

University of Wuerzburg

Enrollment

1,000 participants

Start Date

Jan 1, 2003

Study Type

OBSERVATIONAL

Conditions

Adrenocortical Carcinoma

Summary

Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.

Eligibility

Plain Language Summary

Simplified for easier understanding

This registry collects detailed clinical and biological information from patients with adrenocortical carcinoma (cancer of the adrenal gland) across Germany, to improve understanding and treatment of this rare cancer. **You may be eligible if...** - You have been diagnosed with adrenocortical carcinoma (cancer of the outer layer of the adrenal gland) - You are receiving care at a participating German medical center - You are willing to have your medical data and tissue samples included in the registry **You may NOT be eligible if...** - Your adrenal tumor is benign (not cancerous) - You are not being treated at a participating center - You are unable or unwilling to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of Wuerzburg

Würzburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00453674

Related Trials

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT041190243 locations

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT0633331422 locations